Recombinant PCSK9 (Recaticimab Biosimilar) antibody

Catalog No. ABIN7676124

The Human Monoclonal anti-PCSK9 (Recaticimab Biosimilar) antibody (ABIN7676124) specifically detects PCSK9 (Recaticimab Biosimilar) in BLI, ELISA, FACS, Func and SPR. The antibody is reactive with Human samples.

Quick Overview for Recombinant PCSK9 (Recaticimab Biosimilar) antibody (ABIN7676124)

Target: PCSK9 (Recaticimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This PCSK9 (Recaticimab Biosimilar) antibody is un-conjugated

Application: Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-PCSK9 (Recaticimab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-PCSK9 Reference Antibody (recaticimab)

Characteristics: Anti-PCSK9 Reference Antibody (recaticimab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for PCSK9 (Recaticimab Biosimilar)

Target: PCSK9 (Recaticimab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: Q8NBP7